These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 18257039

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion.
    Chen JT, Kuhlmann T, Jansen GH, Collins DL, Atkins HL, Freedman MS, O'Connor PW, Arnold DL, Canadian MS/BMT Study Group.
    Neuroimage; 2007 Jul 15; 36(4):1152-8. PubMed ID: 17543541
    [Abstract] [Full Text] [Related]

  • 3. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis.
    van den Elskamp IJ, Knol DL, Vrenken H, Karas G, Meijerman A, Filippi M, Kappos L, Fazekas F, Wagner K, Pohl C, Sandbrink R, Polman CH, Uitdehaag BM, Barkhof F.
    Mult Scler; 2010 Jun 15; 16(6):660-9. PubMed ID: 20350960
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
    Dwyer M, Bergsland N, Hussein S, Durfee J, Wack D, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):86-95. PubMed ID: 19386319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
    Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL.
    J Neurol; 2002 Jun 15; 249(6):662-8. PubMed ID: 12111296
    [Abstract] [Full Text] [Related]

  • 8. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T, Antel J, König FB, Brück W, Kuhlmann T.
    Neurology; 2009 Jun 02; 72(22):1914-21. PubMed ID: 19487649
    [Abstract] [Full Text] [Related]

  • 9. Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
    Brown RA, Narayanan S, Arnold DL.
    Neuroimage; 2013 Feb 01; 66():103-9. PubMed ID: 23110887
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Why does remyelination fail in multiple sclerosis?
    Franklin RJ.
    Nat Rev Neurosci; 2002 Sep 01; 3(9):705-14. PubMed ID: 12209119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 01; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
    Cercignani M, Basile B, Spanò B, Comanducci G, Fasano F, Caltagirone C, Nocentini U, Bozzali M.
    NMR Biomed; 2009 Jul 01; 22(6):646-53. PubMed ID: 19322806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.